ACI
AGN

AMP Capital Investors’s Allergan Inc AGN Stock Holding History

AMP Capital Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-148,903
Closed -$31.8M – 1252
2014
Q4 		$31.8M Sell
148,903
-63,431
-30% -$12.6M 0.19% 133
2014
Q3 		$38.2M Buy
212,334
+9,588
+5% +$1.59M 0.24% 104
2014
Q2 		$35.3M Sell
202,746
-714
-0.4% -$111K 0.22% 110
2014
Q1 		$24.6M Buy
203,460
+12,894
+7% +$1.57M 0.17% 151
2013
Q4 		$21.1M Buy
190,566
+31,262
+20% +$2.99M 0.15% 174
2013
Q3 		$14.5M Sell
159,304
-6,055
-4% -$544K 0.11% 212
2013
Q2 		$14.1M Buy
+165,359
New +$17.2M 0.11% 211

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

AMP Capital Investors's AGN Position: Q1 2015 in Review

AMP Capital Investors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 148,903 shares — an estimated $31.8M sold.

AMP Capital Investors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $38.2M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • AMP Capital Investors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • AMP Capital Investors sold 148,903 Allergan Inc shares in Q1 2015, an estimated $31.8M.
  • AMP Capital Investors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • AMP Capital Investors's Allergan Inc position peaked at $38.2M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on AMP Capital Investors's 13F filing for Q1 2015, filed 14 May 2015.